We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
+13.52%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$39M
Cap. Flow
+$31.4M
Cap. Flow %
23.84%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$31.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTL
1
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$54.6M 41.39%
2,956,456
– –
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$32.6M 24.72%
+1,716,303
New +$31.4M
KALV
3
DELISTED
KalVista Pharmaceuticals
KALV
$17.4M 13.16%
2,579,490
– –
ASXC
4
DELISTED
Asensus Surgical, Inc.
ASXC
$10.8M 8.18%
580,515
– –
OCUL icon
5
Ocular Therapeutix
OCUL
$2.38B
$9.92M 7.52%
1,605,207
– –
ATXS
6
DELISTED
Astria Therapeutics
ATXS
$6.06M 4.59%
47,628
– –
EVAR
7
DELISTED
Lombard Medical, Inc.
EVAR
$574K 0.44%
1,275,779
– –

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q3 2017 Portfolio in Review

As of Q3 2017, SV Health Investors held 7 positions worth $132M, up 42% from $92.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors deployed $31.4M of net new capital in Q3 2017, opening 1 new position. Its largest new stake was Deciphera Pharmaceuticals, Inc. Common Stock: 1,716,303 shares worth $32.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • SV Health Investors's largest Q3 2017 buy was Deciphera Pharmaceuticals, Inc. Common Stock: 1,716,303 shares worth $32.6M.
  • SV Health Investors's ten largest holdings make up 100% of its $132M portfolio in Q3 2017.
  • SV Health Investors opened 1 new position and closed 0 in Q3 2017.
  • SV Health Investors's portfolio value rose 42% quarter-over-quarter to $132M.

Based on SV Health Investors's 13F filing for Q3 2017, filed 14 Nov 2017.